259 related articles for article (PubMed ID: 28675698)
1. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
Yang J; Pi C; Wang G
Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
[TBL] [Abstract][Full Text] [Related]
3. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
4. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
6. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
[TBL] [Abstract][Full Text] [Related]
7. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
10. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
[TBL] [Abstract][Full Text] [Related]
11. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy.
Jia YL; Xu M; Dou CW; Liu ZK; Xue YM; Yao BW; Ding LL; Tu KS; Zheng X; Liu QG
Cell Death Dis; 2016 Oct; 7(10):e2400. PubMed ID: 27711074
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q
Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
[TBL] [Abstract][Full Text] [Related]
14. Autophagy inhibition mediated by trillin promotes apoptosis in hepatocellular carcinoma cells via activation of mTOR/STAT3 signaling.
Zhan G; Wei T; Xie H; Xie X; Hu J; Tang H; Cheng Y; Liu H; Li S; Yang G
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1575-1587. PubMed ID: 37676495
[TBL] [Abstract][Full Text] [Related]
15. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.
Sun R; Zhai R; Ma C; Miao W
Cancer Med; 2020 Feb; 9(3):1141-1151. PubMed ID: 31830378
[TBL] [Abstract][Full Text] [Related]
16. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
Choi J; Jo M; Lee E; Lee DY; Choi D
Fertil Steril; 2015 Sep; 104(3):655-64.e1. PubMed ID: 26051103
[TBL] [Abstract][Full Text] [Related]
17. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells.
Gong L; Di C; Xia X; Wang J; Chen G; Shi J; Chen P; Xu H; Zhang W
Int J Oncol; 2016 Dec; 49(6):2538-2548. PubMed ID: 27779641
[TBL] [Abstract][Full Text] [Related]
18. Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma.
Yu H; Qiu Y; Pang X; Li J; Wu S; Yin S; Han L; Zhang Y; Jin C; Gao X; Hu W; Wang T
Mol Cancer Ther; 2017 Dec; 16(12):2711-2723. PubMed ID: 28974556
[TBL] [Abstract][Full Text] [Related]
19. Mesenchyme homeobox 2 has a cancer-inhibiting function in breast carcinoma via affection of the PI3K/AKT/mTOR and ERK1/2 pathways.
Cai Y; Liu Y; Sun Y; Ren Y
Biochem Biophys Res Commun; 2022 Feb; 593():20-27. PubMed ID: 35051778
[TBL] [Abstract][Full Text] [Related]
20. AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation.
Zhou J; Tang Y; Xie ZJ; Lu JN; Deng JH; Huang XW; Chuan Hooi S; He M; Lu GD
Anticancer Drugs; 2017 Apr; 28(4):427-435. PubMed ID: 28085697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
